Clinical trial · Observational
Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome
Letrozole and Chromium
NCT05765305CI-TRIAL-00064720completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Letrozole with chromium | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Letrozole
- description
- Letrozole versus letrozole with chromium
- interventionNames
- Drug: Letrozole with chromium
Primary outcomes (1)
- measure
- Efficacy of letrozole
- timeFrame
- 12 months
- description
- efficacy of letrozole with chromium in improving induction of ovulation
Secondary outcomes (1)
- measure
- Miscarriage rate
- timeFrame
- 12 months
- description
- Incidence of OHSS
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: * female patients aged from 18 to 35 years Anovulatory cycles Pcos Exclusion Criteria: * female patients aged more than 35years Male factor of infertility Other factors of infertility than pcos
References
Publications (0)
Data not yet available
No reference posted for this study.